Mutation of the uracil DNA glycosylase gene detected in glioblastoma.
暂无分享,去创建一个
A. Vortmeyer | R. Weil | W. Park | T. Winters | Z. Zhuang | B. G. Fuller | A. Vortmeyer | Y. Moon | Y. -. Lee | Youn-Soo Lee
[1] I. Pogribny,et al. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. , 1997, Carcinogenesis.
[2] T. Jorgensen,et al. Identification of defective illegitimate recombinational repair of oxidatively-induced DNA double-strand breaks in ataxia-telangiectasia cells. , 1997, Mutation research.
[3] B. Ames,et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] K. Kvaløy,et al. Human uracil-DNA glycosylase gene: sequence organization, methylation pattern, and mapping to chromosome 12q23-q24.1. , 1996, Genomics.
[5] J. Tainer,et al. Excision of cytosine and thymine from DNA by mutants of human uracil‐DNA glycosylase. , 1996, The EMBO journal.
[6] A. Yang,et al. HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. , 1995, Nucleic acids research.
[7] K. Kinzler,et al. The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.
[8] J. Tainer,et al. Crystal structure and mutational analysis of human uracil-DNA glycosylase: Structural basis for specificity and catalysis , 1995, Cell.
[9] M. Walsh,et al. E2F-1 and a Cyclin-like DNA Repair Enzyme, Uracil-DNA Glycosylase, Provide Evidence for an Autoregulatory Mechanism for Transcription (*) , 1995, The Journal of Biological Chemistry.
[10] L. Liotta,et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. , 1995, The American journal of pathology.
[11] L. Liotta,et al. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. , 1995, Cancer research.
[12] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[13] N. Copeland,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.
[14] B. Ames,et al. Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. Rorke,et al. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. , 1993, The New England journal of medicine.
[16] M. Rosenblum,et al. Patterns of proto‐oncogene expression in human glioma cell lines , 1989, Journal of neuroscience research.
[17] T. Sekiya,et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Walker,et al. Epidemiology of brain tumors , 1985, Neurology.
[19] G. Stein. T98G: An anchorage‐independent human tumor cell line that exhibits stationary phase G1 arrest in vitro , 1979, Journal of cellular physiology.
[20] J. Pontén,et al. Properties of human malignant glioma cells in vitro. , 1978, Medical biology.
[21] P. Kleihues,et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.
[22] Lei Li,et al. Characterization of molecular defects in xeroderma pigmentosum group C , 1993, Nature Genetics.
[23] M. Apuzzo. Malignant cerebral glioma , 1990 .